Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an Irish population
BACKGROUND Decreased maternal folate levels are associated with having a child with a neural tube defect (NTD), and periconceptual folic acid supplementation reduces this risk by >50%. Vitamin B12 (as methylcobalamin) is a cofactor for methionine synthase, an enzyme that plays a key role in folat...
Saved in:
Published in: | Birth defects research. A Clinical and molecular teratology Vol. 73; no. 4; pp. 239 - 244 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-04-2005
Wiley |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BACKGROUND
Decreased maternal folate levels are associated with having a child with a neural tube defect (NTD), and periconceptual folic acid supplementation reduces this risk by >50%. Vitamin B12 (as methylcobalamin) is a cofactor for methionine synthase, an enzyme that plays a key role in folate metabolism. Alterations in vitamin B12 metabolism may influence the development of NTDs. Low levels of maternal plasma vitamin B12 and reduced binding of vitamin B12 by transcobalamin II (TCII) are independent risk factors for NTDs. TCII levels are altered in the amniotic fluid of pregnancies affected by NTDs. Given this evidence, inherited variants in genes involved in vitamin B12 trafficking such as TCII are candidate NTD risk factors.
METHODS
We used case/control and family‐based association methods to investigate whether six common polymorphisms in the TCII gene influence NTD risk. TCII genotypes were determined for more than 300 Irish NTD families and a comparable number of Irish controls.
RESULTS
Allele and genotype frequencies for each polymorphism did not differ between family members and controls.
CONCLUSIONS
These six TCII polymorphisms do not strongly influence NTD risk in the Irish population. The Supplementary Material for this article can be found on the Birth Defects Research (Part A) website http://www.mrw.interscience.wiley.com/suppmat/1542‐0752/suppmat/2005/73/v73.4.swanson.html Birth Defects Research (Part A), 2005. Published 2005 Wiley‐Liss, Inc. |
---|---|
Bibliography: | Pharmacology Research Associate Fellowship from the National Institute of General Medical Sciences A Microsoft Word document that contains Supplementary Table S1: "Odds ratios and 95% confidence intervals calculated by comparing candidate homozygous TCII genotypes in NTD family groups vs. controls". This article is a US government work and, as such, is in the public domain in the United States of America. This article was prepared by a group consisting of both United States government employees and non-United States government employees, and as such is subject to 17 U.S.C. Sec. 105. istex:8828C8CE8E5A8281455401B4F451CBFFD5483311 ark:/67375/WNG-X212KNRQ-P Health Research Board ArticleID:BDRA20122 National Institutes of Health National Human Genome Research Institute National Institute of Child Health and Human Development All authors are members of the Birth Defects Research Group. This article was prepared by a group consisting of both United States government employees and non‐United States government employees, and as such is subject to 17 U.S.C. Sec. 105. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1542-0752 1542-0760 |
DOI: | 10.1002/bdra.20122 |